Merck KGaA suffers CDMO slump after 'sharp drop' in COVID-related sales, CFO says
Fierce Pharma
AUGUST 3, 2023
Merck KGaA’s forecast for a tough 2023 is coming true, as the Darmstadt, Germany-based company’s contract manufacturing division took a major hit from production timing and COVID-related sales down | Merck KGaA’s life science services business unit, which offers contract manufacturing and contract testing services, logged a “strong organic sales decline” (..)
Let's personalize your content